Chase AIPricingFAQs
Display currency
Loading news…

Pyros Pharmaceuticals

ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).
New York, United States Founded 2017 11-50 employees For Profit

Pyros Pharmaceuticals is a generic drug company dedicated to developing and commercializing low-cost generics.

Pyros Pharmaceuticals was acquired by Bora Pharmaceuticals in 2024.
Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
23
Patents
3
10 trademarks

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
12
Patents granted
3
Trademarks
10
Top patent class
Medical Or Veterinary Science; Hygiene
IT spend
$9K

Company Info

Founded
2017
Employees
11-50
Operating status
Closed
Company type
For Profit
Org types
company
Founders
2
News articles
15
HQ
New York, United States
Region
Greater New York Area, East Coast, Northeastern US
Exit date
Oct 25, 2024

Signals & Scores

Heat score
Low
Trend (7d)
-0.1
Trend (30d)
0.1
Trend (90d)
1.5

Key People at Pyros Pharmaceuticals

Co-Founder and Chief Executive Officer
23
professional contacts at Pyros Pharmaceuticals
Contact execs at Pyros Pharmaceuticals

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Pyros Pharmaceuticals

Loading news…

FAQs about Pyros Pharmaceuticals

People who checked this page also checked these

Browse the full Acquirezy directory.
Pyros Pharmaceuticals - Company Profile, Full Acquisitions List, Funding and Investments